Teva Pharma CEO on Earnings, Aramco’s AI Strategy, SCOTUS Hears Tariffs Arguments 11/5/25
About this episode
Shares of generics drugmaker Teva Pharma jumping double digits after earnings. Its CEO breaks down the impact of tariffs and price negotiations on margins. Then an inside look at Aramco’s AI strategy, live from its headquarters in Saudi Arabia. Plus, the Supreme Court hears challenges against the Trump administration’s tariff policies. A live report from outside the court room.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time CNBC’s “Money Movers” publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from CNBC’s “Money Movers”
Bridgewater Founder Ray Dalio, Setup for Tech Earnings, Calls for DHS Funding Gr...
CNBC’s “Money Movers”
DOJ Drops Probe into Fed Chair Powell, OpenAI CFO Sarah Friar, CrowdStrike CEO o...
CNBC’s “Money Movers”
Software Tumbles, Chips Jump, Data Center Opportunity with CBRE CEO, Pinnacle Fi...
CNBC’s “Money Movers”
GE Vernona & AI Demand, Philip Morris CEO, SpaceX’s AI Strategy 4/22/26
CNBC’s “Money Movers”